That Many Compounds in Development? Really?

So PhRMA has a press release out on the state of drug research, but it's a little hard to believe. This part, especially: The report, developed by the Analysis Group and supported by PhRMA, reveals that more than 5,000 new medicines are in the pipeline globally. Of these medicines in various phases of clinical development, 70 percent are potential first-in-class medicines, which could provide...